首页>
外国专利>
SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM) FOR USE IN THE TREATMENT OF HEAVY MENSTRUAL BLEEDING
SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM) FOR USE IN THE TREATMENT OF HEAVY MENSTRUAL BLEEDING
展开▼
机译:用于治疗重度经血的选择性孕酮受体调节剂(SPRM)
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention is directed to a pharmaceutical composition comprising a progesterone receptor antagonist namely (11β,17β)-17-Hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one for the treatment and/or prophylaxis of Uterine Fibroids (myomas, uterine leiomyoma) that is administered to a patient diagnosed with Uterine Fibroids following a specific regimen.;Additionally, the invention is directed to a method for treating Uterine Fibroids (myomas, uterine leiomyoma) and/or for reducing Uterine Fibroids (myomas, uterine leiomyoma) size and symptoms related to Uterine Fibroids following a specific regimen as well as treatment of Heavy Menstrual Bleeding (HMB).
展开▼